Welcome to our year-end edition of M&A Insights, where we preview some of the themes we expect to shape deal-making over the next 12 months.
Continued volatility in the debt markets has resulted in another subdued year for...more
12/13/2023
/ Acquisitions ,
Artificial Intelligence ,
Asset Management ,
Capital Markets ,
EU ,
Financial Sponsors ,
Global Dealmaking ,
Global Market ,
Investment ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Publicly-Traded Companies ,
Software Developers ,
Technology
The outlook for public M&A remains challenging, even if we have now reached a plateau in interest rates.
We see two primary areas for opportunity: (i) strategic buyers using the current conditions to accelerate...more
11/6/2023
/ Acquisitions ,
Corporate Governance ,
Denmark ,
EU ,
Foreign Investment ,
Foreign Subsidies ,
Investment Funds ,
Investors ,
Mergers ,
Private Equity ,
Regulatory Reform ,
Regulatory Requirements
Today the 27 member states of the European Union have decided on Amsterdam as the new home of the European Medicines Agency. The decision came after three rounds of voting, with Amsterdam eventually emerging the winner after...more